MichaelAugustBlazingMD

Cardiology • Durham, NC

Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation

Associate Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. Blazing is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Blazing's full profile

Already have an account?

Office
1821 Hillandale Rd
Ste 25B
Durham, NC 27705
Phone+1 919-660-6628
Is this information wrong?

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1991 - 1995
University of California (San Francisco)Internship, Internal Medicine, 1987 - 1988
University of California San Francisco School of MedicineClass of 1987

Certifications & Licensure

CA State Medical License 1989 - Present
NC State Medical License 1995 - 2025
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Top MD Consumers Checkbook

Publications & Presentations

PubMed

Why Novel Therapies in Preventive Cardiology May Face a Marathon, Not a Sprint.
Joanna S Cavalier, Nishant P Shah, Michael A Blazing> ;Circulation. 2023 Sep 12
2 citations
Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT.
Nishant P Shah, Darren K McGuire, Christopher P Cannon, Robert P Giugliano, Yuliya Lokhnygina, Courtney B Page, Andrew M Tershakovec, Eugene Braunwald, Michael A Blazing> ;Journal of the American Heart Association. 2023 Jul 4
17 citations
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
Eri Toda Kato, David A Morrow, Jianping Guo, David D Berg, Michael A Blazing, Erin A Bohula, Marc P Bonaca, Christopher P Cannon, James A de Lemos, Robert P Giugliano,...> ;European Heart Journal. 2023 Jan 21
6 citations
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial.
Vishal N Rao, Anand Shah, Jaime McDermott, Stephanie G Barnes, Evan M Murray, Michelle D Kelsey, Stephen J Greene, Marat Fudim, Adam D DeVore, Chetan B Patel, Michael ...> ;Circulation. Heart Failure. 2023 Feb 1
3 citations
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analy...
Siddharth M Patel, Arman Qamar, Robert P Giugliano, Petr Jarolim, Nicholas A Marston, Jeong-Gun Park, Michael A Blazing, Christopher P Cannon, Eugene Braunwald, David ...> ;JAMA Cardiology. 2022 Dec 1
3 citations
Cardiovascular Events and Long-Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE-IT.
Christopher B Fordyce, Robert P Giugliano, Christopher P Cannon, Matthew T Roe, Abhinav Sharma, Courtney Page, Jennifer A White, Yuliya Lokhnygina, Eugene Braunwald, M...> ;Journal of the American Heart Association. 2022 Feb 15
5 citations
Unexplained Dyspnea on Exertion: The Difference the Right Test Can Make.
Vishal N Rao, Michelle D Kelsey, Michael A Blazing, Neha J Pagidipati, Terry A Fortin, Marat Fudim> ;Circulation. Heart Failure. 2022 Feb 1
74 citations
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Parti...
Nicholas A Marston, Robert P. Giugliano, Giorgio E. M. Melloni, Jeong-Gun Park, Valerie Morrill, Michael A. Blazing, Brian A. Ference, Evan A. Stein, Erik S.G. Stroes,...> ;JAMA Cardiology. 2021 Nov 13
20 citations
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT
Kazuma Oyama, Robert P. Giugliano, Michael A. Blazing, Jeong-Gun Park, Andrew M. Tershakovec, Marc S. Sabatine, Christopher P. Cannon, Eugene Braunwald> ;Journal of the American College of Cardiology. 2021 Oct 12
3 citations
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials
Akash Goyal, Tony Schibler, Brooke Alhanti, Karen L. Hannan, Christopher B. Granger, Michael A. Blazing, Renato D. Lopes, John H. Alexander, Eric D. Peterson, Sunil V....> ;JAMA Network Open. 2021 Jul 1
6 citations
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT
Robert P. Giugliano, Baris Gencer, Stephen D. Wiviott, Jeong-Gun Park, Charles S. Fuchs, Wolfram Goessling, Thomas Musliner, Andrew M. Tershakovec, Michael A. Blazing,...> ;JACC. Cardiooncology. 2020 Sep 1
19 citations
Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.
Nishant P. Shah, Neha J. Pajidipati, Robert W. McGarrah, Ann Marie Navar, Sreekanth Vemulapalli, Michael A. Blazing, Svati H. Shah, Adrian F. Hernandez, Manesh R. Patel> ;The American Journal of Cardiology. 2020 Jul 1
9 citations
A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response.
Rahul S. Loungani, Michael Rehorn, L. Kristin Newby, Jason N. Katz, Igor Klem, Robert J. Mentz, W. Schuyler Jones, Sreekanth Vemulapalli, Anita M. Kelsey, Michael A. B...> ;American Heart Journal. 2020 May 3
1 citations
Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/Simvastatin
Michael G. Nanna, Ann Marie Navar, Robert P. Giugliano, Jennifer A. White, Yuliya Lokhnygina, Yale B. Mitchel, Thomas Musliner, Christopher P. Cannon, Michael A. Blazing> ;Journal of the American College of Cardiology. 2020 Feb 25
Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply.
Richard G. Bach, Christopher P. Cannon, Michael A. Blazing> ;JAMA Cardiology. 2020 Feb 1
64 citations
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomi...
Richard G. Bach, Christopher P. Cannon, Robert P. Giugliano, Jennifer White, Yuliya Lokhnygina, Erin A. Bohula, Robert M. Califf, Eugene Braunwald, Michael A. Blazing> ;JAMA Cardiology. 2019 Sep 1
29 citations
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial
Arman Qamar, Robert P. Giugliano, Erin A. Bohula, Jeong-Gun Park, Petr Jarolim, Sabina A. Murphy, Michael A. Blazing, Robert M. Califf, Christopher P. Cannon, Eugene B...> ;Journal of the American College of Cardiology. 2019 Aug 27
3 citations
Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT).
Abhinav Sharma, Jie-Lena Sun, Yuliya Lokhnygina, Matthew T. Roe, Tariq Ahmad, Nihar R. Desai, Michael A. Blazing> ;The American Journal of Cardiology. 2019 Apr 15
397 citations
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jane Armitage, Colin Baigent, Elizabeth H Barnes, D. John Betteridge, Lisa Blackwell, Michael A. Blazing, Louise Bowman, Eugene Braunwald, Robert P Byington, Christoph...> ;Lancet. 2019 Feb 2
20 citations
Medication Discontinuation in the IMPROVE-IT Trial.
Ann Marie Navar, Matthew T. Roe, Jennifer White, Christopher P. Cannon, Yuliya Lokhnygina, L. Kristin Newby, Robert P. Giugliano, Andrew M. Tershakovec, Eugene Braunwa...> ;Circulation. Cardiovascular Quality and Outcomes. 2019 Jan 1
46 citations
Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF
Marat Fudim, Arun Ganesh, Cynthia L. Green, W. Schuyler Jones, Michael A. Blazing, Adam D. DeVore, G. Michael Felker, Todd L. Kiefer, David F. Kong, Richard L. Boortz-...> ;European Heart Journal. 2018 Dec 21
73 citations
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial.
Marc P. Bonaca, J. Antonio Gutierrez, Christopher P. Cannon, Robert P. Giugliano, Michael A. Blazing, Jeong-Gun Park, Jennifer White, Andrew M. Tershakovec, Eugene Bra...> ;The Lancet. Diabetes & Endocrinology. 2018 Dec 1
42 citations
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.
Tracey G. Simon, Kathleen E. Corey, Christopher P. Cannon, Michael A. Blazing, Jeong-Gun Park, Michelle L. O'Donoghue, Raymond T. Chung, Robert P. Giugliano> ;International Journal of Cardiology. 2018 Nov 1
2 citations
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status.
Andrew P. Ambrosy, Lukasz P. Cerbin, Marat Fudim, Robert M. Clare, Yuliya Lokhnygina, Eugene Braunwald, Robert M. Califf, Christopher P. Cannon, Andrew M. Tershakovec,...> ;The American Journal of Cardiology. 2018 Nov 1
9 citations
Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach.
Shu Yang, Anastasios A. Tsiatis, Michael A. Blazing> ;Biometrics. 2018 Jan 22
Join now to see all

Lectures

31st Annual Cardiovascular Conference at Snowshoe
CAMC Health Education and Research Institute, Snowshoe, West Virginia - 1/27/2012

Hospital Affiliations

Duke University HospitalDurham, North Carolina
Durham Veterans Affairs Medical CenterDurham, North Carolina